# Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma

> **NCT06705335** · — · RECRUITING · sponsor: **Institut Bergonié** · enrollment: 50 (estimated)

## Conditions studied

- Pancreas Cancer

## Interventions

- **OTHER:** Blood sample

## Key facts

- **NCT ID:** NCT06705335
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-27
- **Primary completion:** 2028-01
- **Final completion:** 2029-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06705335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06705335, "Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT06705335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*